Play Earnings CallPlay Earnings Call
Sandoz Group AG (SDZNY) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 12:45 PM EST
Company Participants
Richard Saynor – Chief Executive Officer
Keren Haruvi – President of North America
Remco Steenbergen – Chief Financial Officer
Conference Call Participants
Sophia Graeff Buhl Nielsen – JPMorgan Chase & Co, Research Division
Peter Testa – One Investments S.A.G.L.
Presentation
Sophia Graeff Buhl Nielsen
JPMorgan Chase & Co, Research Division
Good morning, and welcome to the Sandoz session of the 44th JPMorgan Healthcare Conference. My name is Sophia Graeff Buhl Nielsen. I’m an analyst here at JPMorgan on the European pharma and biotech team. And today, it’s my pleasure to welcome CEO of Sandoz, Richard Saynor. [Operator Instructions] And with that, I’ll hand over to Richard.
Richard Saynor
Chief Executive Officer
Okay. Well, thank you. Pleasure. And good morning, everybody. So I’ll take you through a relatively brief presentation, talk about a bit of our history, our journey, how we’re executing and then really much more importantly, thinking about the future, as we see it over the few years and an opportunity for questions. What I have said is we’ll have a money box. Any questions on GLP-1s, we’ll collect some money for disadvantaged Canadians because clearly, I’m getting a lot of questions on GLPs. So pioneering for access for patients. So good morning. Our mission as a company is simple. Our job is to pioneer access for patients. We treat more patients around the world than pretty much other pharmaceutical company in an area where patients are getting older, patients are getting sicker and affordability is becoming an increasing issue for many societies.
The role that Sandoz and companies like Sandoz play is increasingly critical and the role that we make for patients is a huge difference. I want to talk you through today
